Fritextsökning
Innehållstyper
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Han blir ny vd på Bactiguard
Inför börsnoteringen kliver nuvarande vd:n åt sidan till förmån för exportexpert.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Index Pharmaceuticals i jätteaffär
UPPDATERAD: Tecknar mångmiljonavtal med Almirall för Kappaproct och planerar börsnotering.
-
Filter tips for safer pipetting and better accuracy
Biohit has launched new Safetyspace Filter Tips that have more space between the sample and the filter than conventional filter tips usually have.
-
Pengaregn över forskare
Långvariga infektioner, smärta och mitokondriernas genuttryck är några av de ämnen som delar på pengarna när Knut och Alice Wallenbergs Stiftelse delar ut 752 m...
-
Twinrix-reklam frias
Är inte könsdiskriminerande, enligt reklamombudsmannen.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Pharmalundensis får smäll på fingrarna
Personangrepp och att ogrundat anklaga folk för kurspåverkan är inte okej. Det menar Aktietorget som krävt att Pharmalundensis tar tillbaka sitt påhopp mot Astrazeneca.
-
Follicum tar in pengar
Vill ha 38,5 miljoner inför kliniska studier med sitt håravfallspreparat.
-
New type of stem cell discovered
The earlier view of the scientific community was that melanocytes, the pigment cells, derive from the spinal cord during the early fetal period and then move ov...
-
Kärlekens kemi
Urban Fagerholm, docent i farmaci, har på ett vetenskapligt vis i sin nya bok tagit sig an det kanske viktigaste ämnet för mänskligheten – kärleken.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Chatt inspirerade till bättre molnberäkningar
En grupp forskare har byggt en ny teknik för molnberäkningar. Istället för fråga-svar principen bygger programmet på omvänd kommunikation mellan server och dato...
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.